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Mass spectrometric analysis of glycopeptides was performed as described previously by Kapur et al. 2014 . Aliquots of the tryptic digests of total IgG (200 nl) and anti-RBC antibodies (5µl) were applied to a C18 PepMapTM 100um x 20mm trapping column (5 µm, 100 Å; Thermo Scientific) and washed with 100% A (0.1% formic acid in water) at 15 µl/min for 2 minutes. Following valve switching, tryptic (glyco-)peptides were separated on a reverse-phase column (Acclaim C18 PepMap;75 µmx150 mm, 2 µm, 100 Å; Thermo Scientific) at a flow rate of 700 nl/min. The gradient applied was as follows; 18% eluent B (95% acetonitrile, 5% water) in 5 min and 3-27% eluent B in the next 15 min, followed by an isocratic elution with 70% eluent B for 3 min. The LC system was coupled to an AmaZon Speed ETD ion trap MS (Bruker Daltonics, Bremen, Germany) operated in the positive ion mode. The sample was ionized with an CaptiveSprayer (1300 V) using CaptiveSpray tapered spray tip (internal diameter of 20 μm) Microm Bioresources Inc.. The solvent was evaporated at 180 °C with a nitrogen flow of 3 liters/min. A CaptiveSpray nanoBooster (Bruker Daltonics) was mounted onto the mass spectrometer and saturated the nitrogen flow with acetonitrile to enhance the sensitivity (0.2bar). The MS1 ion detection window was set at m/z 550-1800. The HPLC method resulted in separation of the glycopeptides based on the peptide moiety with IgG1 glycopeptides eluting first, followed by the elution of IgG4 and lastly IgG2 and IgG3 glycopeptides (Wuhrer et al. 2007 , Selman et al. 2012 , Kapur et al. 2014 . Moreover, glycopeptides with neutral glycan moieties tended to elute earlier than glycopeptides with antennae sialylation, as described before. For both the neutral and the acidic glycopeptides of each IgG subclass, average mass spectra were generated over a 0.6 min elution range using Bruker DataAnalysis 4.0.. Glycopeptides were assigned on the basis of mass, retention time (RT)and CID fragmentation pattern, and interference from Fab glycans as well as from other IgG subclasses and antibodies were excluded. We focused on IgG1, without analyzing IgG3 due to the interference with IgG2. The primary data processing was done as described before (Selman et al. 2012 , Plomp et al. 2015 . First, the mass spectra were calibrated internally with Bruker DataAnalysis 4.0 using a list of known glycopeptides, subsequently the runs were exported to the open mzXML format by Bruker DataAnalysis 4.0 in batch mode. Using msalign2, the runs were aligned to a master-run of a representative sample, using a list of known glycopeptides. For the extraction of the glycopeptide signal intensities, the in-house tool 3D Max Extractor was used. This program examines the data points in a given m/z and RT window, respectively +/-0.07 Th and +/-30 s, and reports the maximum intensity observed per predefined analyte (m/z, RT combination). For each IgG1 glycoform the intensities of the first three isotopic peaks, both in their doubly and triply charged form, were background corrected and summed. The absolute values were normalized to the subclass-specific sum of signals. The second isotopic peak for IgG1 G0 and G1S as well as the third isotypic peak for IgG1 G1S were obscured by overlapping peaks, and therefore the signal for these peaks was estimated based on the signal of the remaining isotopic peaks and the theoretical isotopic pattern.
The levels of bisection, fucosylation, and antenna galactosylation and sialylation were calculated on the basis of the normalized intensities of IgG1 Fc glycopeptides according to the formulas presented in supplementary table 2. . The data present individual observations with median. Statistical analysis was done using unpaired t-tests, after 5% FDR correction p-values ≤0.0074 were considered statistically significant.
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